Count-based size-correction analysis of maternal plasma DNA for improved noninvasive prenatal detection of fetal trisomies 13, 18, and 21

American Journal of Translational Research

Volumn 9, Issue 7, 2017, Pages 3469-3473

  Zhang, Li ^a,b   Zhu, Qian ^a   Wang, He ^a   Liu, Shanling ^a  

^a SICHUAN UNIVERSITY   (China)

^b Department of Orthopaedics   (China)

Author keywords

Crossover study; Fetal aneuploidy; Noninvasive prenatal testing; Trisomy; Z score

Indexed keywords

DNA;

ADULT; AMNION FLUID CYTOLOGY; ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; CYTOGENETICS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FETUS DISEASE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ALGORITHM; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MATERNAL PLASMA; PRENATAL DIAGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TRISOMY 13; TRISOMY 18; TRISOMY 21;

EID: 85025596347     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Ke WL, Zhao WH and Wang XY. Detection of fetal cell-free DNA in maternal plasma for Down syndrome, Edward syndrome and Patau syndrome of high risk fetus. Int J Clin Exp Med 2015; 8: 9525-9530.
2. Manegold-Brauer G, Berg C, Flock A, Ruland A, Gembruch U and Geipel A. Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center. Arch Gynecol Obstet 2015; 292: 543-548.
3. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW and Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487.
4. Chiu RW, Chan KC, Gao Y, Lau VY, Zheng W, Leung TY, Foo CH, Xie B, Tsui NB, Lun FM, Zee BC, Lau TK, Cantor CR, Lo YM. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 2008; 105: 20458-20463.
5. Chan KC, Zhang J, Hui AB, Wong N, Lau TK, Leung TN, Lo KW, Huang DW, Lo YM. Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50: 88-92.
6. Lo YM, Chan KC, Hao S, Chen EZ, Peiyong J, Lun FM, Zheng YW, Leung TY, Lau TK and Cantor CR. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010; 2: 841-849.
7. Yu SC, Chan KC, Zheng YW, Jiang P, Liao GJ, Sun H, Akolekar R, Leung TY, Go AT, van Vugt JM, Minekawa R, Oudejans CB, Nicolaides KH, Chiu RW, Lo YM. Size-based molecular diagnostics using plasma DNA for noninvasive prenatal testing. Proc Natl Acad Sci 2014; 111: 8583-8588.
8. Wang J, Liu Z, Liu H, Li N, Li S, Chen X, Lin Y, Wang H, Zhu J and Liu S. Rapid detection of aneuploidy and unbalanced chromosomal rearrangements by subtelomeric multiplex ligation-dependent probe amplification in fetuses with congenital heart disease. Fetal Diagn Ther 2013; 34: 110-115.
9. Chiu RW, Akolekar R, Zheng YW, Leung TY and Sun H. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342: c7401-c7401.
10. Canick JA, Palomaki GE, Kloza EM, Lambert-Messerlian GM and Haddow JE. The impact of maternal plasma DNA fetal fraction on next generation sequencing tests for common fetal aneuploidies. Prenat Diagn 2013; 33: 667-674.
11. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011; 13: 913-920.